Through
10/10
Cancer Research
Why new cancer treatment discoveries are proliferating
Why new cancer treatment discoveries are proliferating
The approval of CAR T cell therapy ushered in a new era for cancer treatment.
The path from innovation to implementation
The path from innovation to implementation
Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from idea to approval.
Three things to know about BRCA mutations in men
Three things to know about BRCA mutations in men
Kara Maxwell, director of the Men & BRCA Program at the Basser Center, is bridging the knowledge gap about how BRCA mutations affect men.
Improved gene editing method could power future cell and gene therapies
Improved gene editing method could power future cell and gene therapies
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Why Penn research powers many FDA-approved treatments
Why Penn research powers many FDA-approved treatments
Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
Running and walking for oral cancer awareness
Running and walking for oral cancer awareness
In a student-led effort, the School of Dental Medicine hosted the Oral Cancer Walk & 5K. The event has been an annual tradition since 2009, offering both a community celebration and a venue for discussing oral cancer prevention and detection.
More cancers may be treated with drugs than previously believed
More cancers may be treated with drugs than previously believed
Using a Penn-designed neural network called PocketMiner, a Penn Medicine research team has identified hidden protein pockets that can provide new opportunities for cancer drugs to bind to.
A potential strategy to improve T cell therapy in solid tumors
A potential strategy to improve T cell therapy in solid tumors
A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
A moment for men’s health
A moment for men’s health
Since 2012, the Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center has been advancing lifesaving therapies and raising awareness of the risks faced by individuals with BRCA gene mutations.
Can we intercept cancer?
Can we intercept cancer?
Penn researchers are developing new ways to detect and “intercept” cancer from every angle, including basic science to understand the molecular changes that lead to cancer and developing new methods for finding it.
In the News
Scientific American
Pancreatic cancer vaccine shows promise in small initial trial
Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness.
FULL STORY →
USA Today
Cutting-edge advances in cancer treatment are underway. Here are three that could change lives
Robert Vonderheide and Constantinos Koumenis of the Perelman School of Medicine discuss the major advancements occurring in cancer surgery and cancer radiation, two fundamental tools of cancer treatment.
FULL STORY →
The Wall Street Journal
Moderna, Merck show progress toward cancer vaccines
Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.
FULL STORY →
USA Today
In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma
According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly.
FULL STORY →
Associated Press
Novel treatment shows promise against rare cancer in kids
Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer.
FULL STORY →
Hindustan Times (Delhi)
T cells therapy in solid tumors shows improvement
A preclinical study by researchers at the Perelman School of Medicine is using a novel “one-two punch” strategy to assist T cells in attacking solid tumors.
FULL STORY →